Imagion Biosystems Overview
- Status
-
Public
- Employees
-
19

- Stock Symbol
-
IBX

- Share Price
-
$0.01
- (As of Monday Closing)
Imagion Biosystems General Information
Description
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Contact Information
Website
www.imagionbiosystems.comCorporate Office
- 100 Albert Road
- Level 4
- South Melbourne, Victoria 3205
- Australia
Corporate Office
- 100 Albert Road
- Level 4
- South Melbourne, Victoria 3205
- Australia
Imagion Biosystems Stock Performance
As of 24-Mar-2025, Imagion Biosystems’s stock price is $0.01. Its current market cap is $2.15M with 201M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.01 | $0.01 | $2.15M | 201M | 1.11M |
Imagion Biosystems Financials Summary
As of 31-Dec-2024, Imagion Biosystems has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 2,990 | 2,990 | 11,461 | 15,869 |
Revenue | 908 | 328 | ||
EBITDA | (6,791) | (5,925) | ||
Net Income | (8,279) | (6,792) | ||
Total Assets | 3,125 | 6,786 | ||
Total Debt | 4,114 | 3,132 |
Imagion Biosystems Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Imagion Biosystems Patents
Imagion Biosystems Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200187822-A1 | Detection, measurement, and imaging of cells using cellular internalization of nanoparticles | Inactive | 15-Dec-2018 | ||
US-20170210773-A1 | Synthesis of metal carboxylate compounds | Inactive | 02-Jun-2014 | ||
US-20150293004-A1 | Viscosity measuring method | Inactive | 01-Mar-2011 | ||
US-20160022196-A9 | Nonsurgical determination of organ transplant condition | Inactive | 16-Mar-2010 | ||
US-9095270-B2 | Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof | Active | 06-Nov-2009 | A61B5/0515 |
Imagion Biosystems Signals
Imagion Biosystems FAQs
-
Where is Imagion Biosystems headquartered?
Imagion Biosystems is headquartered in South Melbourne, Australia.
-
What is the size of Imagion Biosystems?
Imagion Biosystems has 19 total employees.
-
What industry is Imagion Biosystems in?
Imagion Biosystems’s primary industry is Other Devices and Supplies.
-
Is Imagion Biosystems a private or public company?
Imagion Biosystems is a Public company.
-
What is Imagion Biosystems’s stock symbol?
The ticker symbol for Imagion Biosystems is IBX.
-
What is the current stock price of Imagion Biosystems?
As of 24-Mar-2025 the stock price of Imagion Biosystems is $0.01.
-
What is the current market cap of Imagion Biosystems?
The current market capitalization of Imagion Biosystems is $2.15M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »